Skip to main content
Log in

Fibronectin expression in human mesangial cell cultures and its alterations by adriamycin

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

Human mesangial cell (HMC) cultures synthesize cellular fibronectin (FN), which is secreted and incorporated into a fibrillar extracellular matrix (ECM). The anticancer drug adriamycin (ADR) induces changes in extracellular FN deposition. As revealed by immunofluorescence staining, a 24 h incubation of the cells with 2 μg ADR/ml resulted in a marked expansion of the pericellular FN fibers, which may be due to either an increased synthesis or a decreased FN degradation. The effects of ADR on FN mRNA were analysed by northern hybridization andin vitro translation. Steady-state FN mRNA levels were significantly increased by 60% following ADR administration. However, yields of radioactivity incorporated into FN by cell-free translation remained constant (2.3±0.7%,n=24, vs controls 2.2±0.8% of total radioactivity,n=23). The quality of translation products was not affected by the drug, whereas translation efficiency of total RNA from ADR-treated HMC was only 75% of controls. The data presented suggest a negative feedback control of FN expression on the level of translation. Extracellular FN accumulation in the experimental model of ADR-induced progressive glomerulopathy therefore cannot be explained by an increased FN synthesis, but is rather regarded a consequence of proteinase inhibition. This assumption is compatible with a diminished number of FN fragments recently demonstrated in the culture medium of ADR-treated HMC, and is further corroborated by the loss of urinary FN degradation products accompanying the onset of proteinuria in ADR-treated rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ADR:

adriamycin

BSA:

boyine serum albumin

ECM:

extracellular matrix

EDTA:

ethylenediamine tetraacetic acid

FITC:

fluorescein isothiocyanate

FN:

fibronectin

HMC:

human mesangial cell

PBS:

phosphate buffered saline

PMSF:

phenylmethylsulfonyl fluoride

SDS:

sodium dodecyl sulfate

SDS-PAGE:

SDS-polyacrylamide gel electrophoresis

SSC:

standard saline citrate

SSPE:

standard saline phosphate ethylenediamine tetraacetic acid disodium salt

TGF-β:

transforming growth factor β

References

  • Allen LE, Dubeau L, Alvarez O, Jones PA. Rapid degradation of extracellular matrix proteins by normal human uroepithelial cells. Cancer Res. 1990;50:1897–904.

    Google Scholar 

  • Alonso S, Minty A, Bourlet Y, Buckingham M. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol. 1986;23:11–22.

    Google Scholar 

  • Ayo SH, Radnik RA, Glass II WF et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol. 1991;260 (Renal Fluid Electrolyte Physiol. 29):F185–91.

    Google Scholar 

  • Barrett AJ. The many forms and functions of cellular proteinases. Federation Proc. 1980;39:9–14.

    Google Scholar 

  • Bertani T, Poggi A, Pozzoni R et al. Adriamycin-induced nephrotic syndrome in rats. Sequence of pathological events. Lab Invest. 1982;46:16–23.

    Google Scholar 

  • Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1–7.

    Google Scholar 

  • Boudreau N, Clausell N, Boyle J, Rabinovitch M. Transforming growth factor-β regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation. Lab Invest. 1992;67:350–9.

    Google Scholar 

  • Broggini M, Colombo T, Martini A, Donelli MG. Studies on the comparative distribution and biliary excretion of doxorubicin and 4′-epi-doxorubicin in mice and rats. Cancer Treat Rep. 1980;64:897–904.

    Google Scholar 

  • Cagliero E, Roth T, Roy S, Maiello M, Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem. 1991;266:14244–50.

    Google Scholar 

  • Chandler LA, Bourgeois S. Posttranscriptional down-regulation of fibronectin in N-ras-transformed cells. Cell Growth Differ. 1991;2:379–84.

    Google Scholar 

  • Chen GL, Liu LF. DNA topoisomerases as therapeutic targets in cancer chemotherapy. In: Bailey DM, ed. Annual reports in medicinal chemistry. New York: Academic Press; 1986:257–62.

    Google Scholar 

  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9.

    Google Scholar 

  • Cosio FG, Sedmak DD, Nahman NS Jr. Cellular receptors for matrix proteins in normal human kidney and human mesangial cells. Kidney Int. 1990;38:886–95.

    Google Scholar 

  • DiPersio CM, Jackson DA, Zaret KS. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol Cell Biol. 1991;11:4405–14.

    Google Scholar 

  • Dixon AJ, Burns J, Dunnill MS, McGee JO'D. Distribution of fibronectin in normal and diseased human kidneys. J Clin Pathol. 1980;33:1021–8.

    Google Scholar 

  • Dorr RT, Shipp NG. Effect of interferon, interleukin-2 and tumor necrosis factor on myocardial cell viability and doxorubicin cardiotoxicity in vitro. Immunopharmacol. 1989;18:31–8.

    Google Scholar 

  • Ebihara I, Suzuki S, Nakamura T et al. Extracellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis. J Am Soc Nephrol. 1993;3:1387–97.

    Google Scholar 

  • Gianni L, Corden BJ, Myers CE. The biochemical basis of anthracyclin toxicity and antitumor activity. In: Hodgson JB, Philpot RM, eds. Reviews in biochemical toxicology. New York: Elsevier-North-Holland; 1983:1–82.

    Google Scholar 

  • Grossi de Sa M-F, Martins de Sa C, Harper F, Olink-Coux M, Huesca M, Scherer K. The association of prosomes with some of the intermediate filament networks of the animal cell. J Cell Biol. 1988;107:1517–30.

    Google Scholar 

  • Gwinner W, Jäckle-Meyer I, Stolte H. Origin of urinary fibronectin. Lab Invest. 1993;69:250–5.

    Google Scholar 

  • Hynes RO. In: Rich A, ed. Fibronectins. New York: Springer; 1990.

    Google Scholar 

  • Jackson RJ, Standart N. Do the poly(A) tail and 3′ untranslated region control mRNA translation? Cell. 1990;62:15–24.

    Google Scholar 

  • Kecskemethy N, Schäfer KP. Lectin-induced changes among polyadenylated and non-polyadenylated mRN in lymphocytes. mRNAs for actin, tubulin and calmodulin respond differently. Eur J Biochem. 1982;126:573–82.

    Google Scholar 

  • Kitamura M, Kitamura A, Mitarai T et al. Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem Biophys Res Commun. 1992;185:1048–54.

    Google Scholar 

  • Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med. 1988;318:1657–66.

    Google Scholar 

  • Kornblihtt AR, Vibe-Pedersen K, Baralle FE. Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J. 1984;3:221–6.

    Google Scholar 

  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature. 1970;227:680–5.

    Google Scholar 

  • Mans RJ, Novelli GD. Measurement of the incorporation of radioactive amino acids into protein by a filter-disk method. Arch Biochem Biophys. 1961;94:48–53.

    Google Scholar 

  • Martin M, El Nabout R, Lafuma C, Crechet F, Remy J. Fibronectin and collagen gene expression during in vitro ageing of pig skin fibroblasts. Exp Cell Res. 1990;191:8–13.

    Google Scholar 

  • Mené P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev. 1989;69:1347–424.

    Google Scholar 

  • Mimnaugh EG, Trush MA, Gram TE. A possible role of membrane lipid peroxidation in anthracyclin nephrotoxicity. Biochem Pharmacol. 1986;35:4327–35.

    Google Scholar 

  • Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/W F1 mice. Am J Pathol. 1991;139:437–50.

    Google Scholar 

  • Nakamura T, Fukui M, Ebihara I et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 1993;42:450–6.

    Google Scholar 

  • O'Donnell MP, Michels L, Kasiske B, Raij L, Keane W. Adriamycin-induced chronic proteinuria: a structural and functional study. J Lab Clin Med. 1985;106:62–7.

    Google Scholar 

  • Ogawa K, Izumi S. In vitro synthesis of rainbow trout dynein. J Submicrosc Cytol. 1983;15:371–4.

    Google Scholar 

  • Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest. 1990;86:453–62.

    Google Scholar 

  • Oomura A, Nakamura T, Arakawa M, Ooshima A, Isemura M. Alterations in the extracellular matrix components in human glomerular diseases. Virchows Archiv A Pathol Anat. 1989;415:151–9.

    Google Scholar 

  • Pabst R, Sterzel RB. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int. 1983;24:626–31.

    Google Scholar 

  • Paczek L, Teschner M, Schaefer RM, Kovar J, Romen W, Heidland A. Intraglomerular proteinase activity in adriamycininduced nephropathy. Nephron. 1992;60:81–6.

    Google Scholar 

  • Puissant C, Houdebine L-M. An improvement of the single step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. BioTechniques. 1990;8:148–9.

    Google Scholar 

  • Radeke HH, Meier B, Topley N, Flöge J, Habermehl GG, Resch K. Interleukin 1-α and tumor necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int. 1990;37:767–75.

    Google Scholar 

  • Roberts AB, McCune BK, Sporn MB. TGF-β: Regulation of extracellular matrix. Kidney Int. 1992;41:557–9.

    Google Scholar 

  • Robison TW, Giri SN, Wilson DW. Effects of chronic administration of doxorubicin on myocardial creatine phosphokinase and antioxidant defenses and levels of lipid peroxidation in tissues and plasma of rats. J Biochem Toxicol. 1989;4:87–94.

    Google Scholar 

  • Rosbash M. A comparison ofXenopus laevis oocyte and embryo mRNA. Dev Biol. 1981;87:319–29.

    Google Scholar 

  • Sambrook J, Fritsch EF, Maniatis T. In: Ford N, Nolan C, Ferguson M, eds. Molecular cloning. A laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.

    Google Scholar 

  • Schena FP, Pertosa G: Fibronectin and the kidney. Nephron. 1988;48:177–82.

    Google Scholar 

  • Sonnenbichler J, Zetl I. Mechanisms of silibinin action, V. Influence of silibinin on the synthesis of ribosomal RNA, mRNA and tRNA in rat livers in vivo. Hoppe-Seyler's Z Physiol Chem. 1984;365:555–66.

    Google Scholar 

  • Soose M, Cleffmann G, Jauker F. A characterization ofTetrahymena mRNA by in vitro translation. The effects of culture growth on the recruitment of poly(A)+ and poly(A) RNA. Eur J Protistol. 1989;24:216–24.

    Google Scholar 

  • Soose M, Gwinner W, Grotkamp J, Hansemann W, Stolte H. Altered renal fibronectin excretion in early adriamycin nephrosis of rats. J Pharmacol Exp Ther. 1991;257:493–9.

    Google Scholar 

  • Soose M, Wenzel S, Stolte H. Fibronectin turnover in human mesangial cell cultures as affected by adriamycin. Cell Biol Toxicol. 1993;9:149–64.

    Google Scholar 

  • Soose M, Zulauf J, Bauer M, Stolte H. A comparative study on the response of two established cell lines to adriamycin. Growth and biomass production in human mesangial cell cultures and inTetrahymena thermophila. Eur J Protistol. 1994;30:75–84.

    Google Scholar 

  • Speth PAJ, Raijmakers RAP, Boezeman JBM et al. In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. Eur J Cancer Clin Oncol. 1988;24:667–74.

    Google Scholar 

  • Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M. TGF-β 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 1994;45:525–36.

    Google Scholar 

  • Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145–54.

    Google Scholar 

  • Wrana JL, Overall CM, Sodek J. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur J Biochem. 1991;197:519–28.

    Google Scholar 

  • Yoshioka K, Takemura T, Murakami K et al. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest. 1993;68:154–63.

    Google Scholar 

  • Zähringer J. The regulation of protein synthesis in heart muscle under normal conditions and in the adriamycin-cardiomyopathy. Klin Wochenschr. 1981;59:1273–87.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soose, M., Wenzel, S., Padur, A. et al. Fibronectin expression in human mesangial cell cultures and its alterations by adriamycin. Cell Biol Toxicol 11, 51–63 (1995). https://doi.org/10.1007/BF00769992

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00769992

Key words

Navigation